Bridging the Gap: The Case for Behavioral Health Integration in Reproductive Health Settings

Major Depressive Disorder (MDD) is a significant public health concern globally and nationally, affecting over 264 million people worldwide and one in six individuals during their lifetime (World Health Organization, 2020). Disparities contribute to underscreening, misdiagnosis, and inadequate follow-up care for depressive symptoms in primary care settings, leaving millions untreated. For birthing individuals, the stakes are even higher. Maternal suicide has now emerged as a leading cause of death in the postpartum period, underscoring the urgent need for targeted mental health intervention (Chin et al., 2022). Despite the growing prevalence of depression and its severe implications for maternal health, disparities persist in screening, diagnosis, and treatment, particularly in primary care and OB/GYN settings. Even with validated tools like the PHQ-9, which has demonstrated strong sensitivity and specificity for identifying perinatal depression (Wang et al., 2021), screening alone is insufficient if not followed by timely and appropriate intervention. Research has shown that even in practices with universal screening protocols, significant gaps remain in ensuring that patients who screen positive are connected to further evaluation or treatment (Miller et al., 2019). These missed opportunities often result in delayed care, worsening symptoms, and increased risk for both parent and child. The lack of integrated behavioral health services in reproductive care settings continues to leave many without the support they critically need.

A systematic review and meta-analysis found that suicide attempts, while often underrecognized, are a significant contributor to maternal morbidity and mortality, particularly in the postpartum period (Gelabert et al., 2024). The study underscores the urgent need for surveillance and targeted intervention, noting that a substantial increase in psychological vulnerability and risk for self-harm marks the postpartum period. We must understand that suicides are preventable and are the result of untreated mental health disorders. A nationwide population-based study by Lee et al. (2022) found a strong association between postpartum depression and increased risk of maternal suicide, reinforcing the urgent need for early detection and intervention. The study highlights that individuals with postpartum depression are significantly more likely to experience suicidal ideation and behavior, contributing to maternal mortality rates during the first year after childbirth. Despite this substantial burden, behavioral health remains siloed from most OB/GYN and maternal health care settings. Without routine mental health integration, opportunities for early identification and intervention are frequently missed, allowing symptoms to progress unchecked.

Depression, particularly among expectant and postpartum women, can lead to poor maternal outcomes. Integrated care and specialized mental health support for these patients remain limited, highlighting a significant gap in the provision of holistic care. This lack of screening increases the risk of worsening symptoms due to delayed identification and intervention. Many OB/GYN providers are the sole point of contact with the healthcare system for birthing individuals, especially those from underserved communities. Yet, without embedded behavioral health services, these clinical encounters are often missed opportunities to screen, identify, and treat mental health conditions early.

Routine screening for depression in reproductive health settings should not be a matter of provider discretion or clinical urgency, it must be standardized and embedded as a core element of patient care. Relying on reactive responses to visible distress or self-disclosure perpetuates disparities and delays treatment. Instead, proactive, universal screening ensures that all patients, regardless of presenting complaint, are routinely assessed for depressive symptoms. Blake (2022) highlights the value of a structured approach in her quality improvement project, which implemented routine PHQ-9 screening among first responders in a primary care clinic. Incorporating routine PHQ-9 screening into every annual visit, prenatal checkup, and postpartum follow-up helps normalize mental health conversations and reduces the stigma that often prevents disclosure. It also provides a structured, repeatable method for identifying patients in need of further evaluation or treatment, well before symptoms escalate into crises. A truly integrated model links screening directly to actionable next steps, supported by trained staff, embedded behavioral health providers, or external referral networks.

References

Blake, C. (2022). Depression screening implementation: a quality improvement project for first

responders in a primary care clinic. Workplace Health & Safety, 70(12), 543–550. https://doi.org/10.1177/21650799221119147

Chin K, Wendt A, Bennett IM, Bhat A. Suicide and Maternal Mortality. Curr Psychiatry Rep. 2022 Apr;24(4):239-275. doi: 10.1007/s11920-022-01334-3. Epub 2022 Apr 2. PMID: 35366195; PMCID: PMC8976222.

Gelabert E, Plaza A, Roca-Lecumberri A, Bramante A, Brenna V, Garcia-Esteve L, Lega I, Subirà S, Toscano C, Torres-Giménez A. Suicide Attempts during Pregnancy and Postpartum: A Systematic Review and Meta-Analysis. Matern Child Health J. 2024 Sep;28(9):1443-1453. doi: 10.1007/s10995-024-03956-w. Epub 2024 Jun 29. PMID: 38951296; PMCID: PMC11358321.

Lee YL, Tien Y, Bai YS, Lin CK, Yin CS, Chung CH, Sun CA, Huang SH, Huang YC, Chien WC, Kang CY, Wu GJ. Association of Postpartum Depression with Maternal Suicide: A Nationwide Population-Based Study. Int J Environ Res Public Health. 2022 Apr 23;19(9):5118. doi: 10.3390/ijerph19095118. PMID: 35564525; PMCID: PMC9099720.

Liu, Q., He, H., Yang, J., Feng, X., Zhao, F., & Lyu, J. (2020). Changes in the global burden of

Depression from 1990 to 2017: Findings from the Global Burden of Disease study. Journal of Psychiatric Research, 126, 134-140. https://doi.org/10.1016/j.jpsychires.2019.08.002

Miller, E. S., Wisner, K. L., Gollan, J., Hamade, S., Gossett, D. R., & Grobman, W. A. (2019). Screening and Treatment After Implementation of a Universal Perinatal Depression Screening Program. Obstetrics and Gynecology, 134(2), 303–309. https://doi.org/10.1097/AOG.0000000000003369

Wang, L., Kroenke, K., Stump, T. E., & Monahan, P. O. (2021). Screening for perinatal

depression with the Patient Health Questionnaire depression scale (PHQ-9): A systematic review and meta-analysis. General Hospital Psychiatry, 68, 74–82. https://doi.org/10.1016/j.genhosppsych.2020.12.007

World Health Organization (2020). Depression. Retrieved from https://www.who.int/health-

topics/depression#tab=tab_1